SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-19-028605
Filing Date
2019-05-10
Accepted
2019-05-10 16:02:19
Documents
8
Period of Report
2019-06-19
Effectiveness Date
2019-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A a19-9618_1def14a.htm DEF 14A 1420664
2 GRAPHIC g96181bqi001.gif GRAPHIC 1497
3 GRAPHIC g96181bqi002.gif GRAPHIC 1652
4 GRAPHIC g96181bqi003.gif GRAPHIC 1760
5 GRAPHIC g96181bqi004.gif GRAPHIC 12078
6 GRAPHIC g96181cai001.gif GRAPHIC 230786
7 GRAPHIC g96181cai002.gif GRAPHIC 133441
8 GRAPHIC g96181boi001.gif GRAPHIC 6457
  Complete submission text file 0001104659-19-028605.txt   1956410
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-36294 | Film No.: 19814792
SIC: 2834 Pharmaceutical Preparations